Skip to content

Clinical trials

Phase 1/2 Adenocarcinoma of Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 1/2 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20071
20082
20113
20142
20171
20181
20191
20222
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated6
Withdrawn3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
Radiation Therapy Oncology Group2
Agennix1
Alaunos Therapeutics1
Amgen1
AstraZeneca1
Intima Bioscience, Inc.1
Janssen Research & Development, LLC1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung22
Carcinoma, Non-Small-Cell Lung14
Lung Neoplasms12
Adenocarcinoma, Bronchiolo-Alveolar3
Cholangiocarcinoma2
Endometrial Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Adenocarcinoma1
Carcinoma, Large Cell1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.